March 7th, 2024 “EURETINA-Brief”© Issue No. 287
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the March 7th, 2024 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA…
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the March 7th, 2024 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA…
Ocugen Inc., (NASDAQ:OCGN), an ophthalmic biopharmaceutical company based in Malvern, Pennsylvania, has announced positive clinical…
Researchers at Newcastle University and Sunderland Eye Infirmary, UK, have reported that, to date, there…
Researchers at the Department of Ophthalmology, at The Hebrew University of Jerusalem, have reported a…
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the March 7th,…